Taiwan

Market Entry & Growth in Taiwan

Taiwan's advanced healthcare system, tech-savvy population, and TFDA regulatory framework make it one of Asia-Pacific's most rewarding markets for life-sciences brands. Taevas delivers the local expertise, regulatory guidance, and commercial networks to a

TFDA Registration

GMP Certification

ISO 13485

Get Taiwan Assessment

$22B+

Healthcare Market Size

Top 15

Global Pharma Market Rank

23.5M

Population

Cities & Counties Covered

Industries We Support

Four Industries. One Taiwan Team.

Select an industry to see regulatory pathways, services, and how Taevas supports your Taiwan market entry.

Medical Devices & Equipment

Taiwan Food and Drug Administration (TFDA), Ministry of Health and Welfare

Taiwan's medical device market is valued at over USD 3 billion and is driven by a universal National Health Insurance system that creates consistent demand for innovative diagnostics, imaging, and therapeutic equipment. The TFDA classifies devices into four risk classes and requires a Medical Device License (MDL) prior to commercialization, with requirements aligned closely to international IMDRF standards. Taevas provides end-to-end registration support, local technical file preparation, and post-market surveillance management to ensure compliant and efficient market access.

Regulatory Pathways

Mandatory

Medical Device Classification

TFDA assigns devices to Class I through Class IV based on risk level, determining the registration pathway, review timeline, and technical documentation requirements. Correct classification at the outset prevents costly re-submissions and delays.

High Risk

Medical Device License Application

All Class II, III, and IV devices require a full MDL application submitted to TFDA, including technical files, clinical data, and quality system certificates. Class I devices may qualify for a simplified notification procedure depending on intended use.

Mandatory

Import and Customs Clearance

Medical devices imported into Taiwan require a licensed local importer or agent, valid MDL documentation, and compliance with customs declaration requirements under the Medical Devices Act. Taevas coordinates all import logistics to ensure seamless border clearance.

Ongoing

Post-Market Surveillance

License holders must maintain adverse event reporting, periodic safety update reports, and field safety corrective actions in accordance with TFDA post-market requirements. Taevas manages ongoing vigilance obligations to keep your MDL in good standing.

Our Services for Medical Devices in India

Market Intelligence

Market sizing, competitive landscape, and pricing benchmarks across Class I–III devices, IVDs, and SaMD. Maps TFDA registration pathways, NHI reimbursement, and MOHW procurement across Taipei and Kaohsiung.

Product Registration

End-to-end TFDA medical device registration under the Medical Devices Act — device classification, QSD audit, technical-file preparation, and post-approval listing. CE / FDA conformity bridging.

Legal Representation

In-country authorised representative under TFDA medical device rules — Taiwan address of record, agency correspondence, post-market surveillance reports, and regulatory contact for inspections.

End-to-End Marketing Support

Brand strategy, medical detailing, and field activation for Taiwanese clinical and procurement audiences — KOL programmes, CME, and TFDA-compliant scientific outreach in Traditional Chinese.

Why Taevas Taiwan

Why Global Brands Choose Taevas for Taiwan

Taevas combines deep TFDA regulatory expertise with established commercial networks across Taiwan's healthcare, pharmacy, and retail channels, giving life-sciences brands a proven path from registration to revenue.

Regulatory

TFDA Regulatory Mastery

Our Taiwan regulatory team has hands-on experience navigating TFDA submissions across medical devices, pharmaceuticals, cosmetics, and health food categories, reducing approval timelines and minimizing deficiency responses.

Market Coverage

Pan-Taiwan Market Reach

Taevas maintains active commercial relationships across Taiwan's 22 cities and counties, spanning major medical centers in Taipei, Taichung, and Kaohsiung as well as regional hospital networks and community pharmacy chains.

Speed

Accelerated Time to Market

Our structured market entry methodology and pre-built TFDA submission templates compress typical registration timelines, enabling clients to reach Taiwan's healthcare professionals and consumers faster than competitors working without local partners.

Distribution

Established Distributor Network

Taevas has cultivated a vetted network of Taiwan distributors across medical, pharmaceutical, beauty, and health food sectors, enabling brands to select channel partners with proven track records and existing customer relationships.

KOL Network

KOL and Clinical Community Access

We maintain trusted relationships with Taiwan's leading clinicians, pharmacists, dietitians, and beauty professionals, enabling effective KOL programmes that drive clinical adoption and consumer brand credibility.

Track Record

Proven Track Record in Asia-Pacific

Taevas has guided numerous international life-sciences brands through successful Taiwan market entries, delivering measurable commercial outcomes across NHI-listed products, retail launches, and direct-to-consumer campaigns.

We Also Operate In

Australia Bangladesh Hong Kong India Malaysia New Zealand Singapore South Korea Sri Lanka Thailand

Get Started

Ready to Enter the Taiwan Market?

Speak with a Taevas Taiwan specialist today and receive a tailored market entry assessment covering TFDA regulatory pathways, commercial timelines, and the right distribution strategy for your product category.

Free Taiwan assessment

TFDA-certified regulatory specialists

Nationwide distributor coverage

End-to-end to revenue